Skip to content
718-732-405019 Fayette Street 4th Floor Brooklyn, NY 11206info@honcology.com
Facebook page opens in new windowLinkedin page opens in new windowX page opens in new window
Hirschfeld Oncology
Advanced Oncology for Stage 4 Cancer Patients
Hirschfeld OncologyHirschfeld Oncology
  • HOME
  • ABOUT US
    • CREDENTIALS
    • INFUSION CENTER
  • PLANS OF CARE
    • IMMUNOTHERAPY
    • LOW-DOSE CHEMO
    • TARGETED THERAPY
    • INNOVATIVE TREATMENTS
  • CANCERS WE TREAT
    • BILE DUCT
    • COLON
    • ESOPHAGEAL
    • OVARIAN
    • PANCREATIC
    • BREAST
    • GASTRIC
    • LUNG
    • UTERINE
    • LIVER
  • BLOG
    • ANSWERS
Make an appointment
Search:
  • HOME
  • ABOUT US
    • CREDENTIALS
    • PRIVACY POLICY
  • PLANS OF CARE
    • IMMUNOTHERAPY
    • LOW-DOSE CHEMO
    • TARGETED THERAPY
    • CLINICAL TRIALS
  • CANCERS WE TREAT
    • BILE DUCT
    • COLON
    • ESOPHAGEAL
    • OVARIAN
    • PANCREATIC
    • BREAST
    • GASTRIC
    • LUNG
    • UTERINE
    • LIVER
  • BLOG
    • ANSWERS
  • CONTACT

Daily Archives: October 26, 2011

You are here:
  1. Home
  2. 2011
  3. October
  4. 26

Patient's Survival Serves as Testimony to Tolerability and Efficacy of Alternative Cancer Therapy Treatment

Tolerability and Efficacy of Alternative Cancer Therapy Treatment

Cancer Case Study, Pancreatic CancerBy Editorial BoardOctober 26, 2011Leave a comment

Tolerability and Efficacy of Alternative Cancer Therapy Treatment. Metastatic pancreatic cancer with comorbidities. Less toxic regimen.

Go to Top